Supply chain
BIO Asia-Taiwan 2019 to see presence of 20 advanced biotech nations
Mark Tsai, Taipei; Willis Ke, DIGITIMES

The 2019 BIO Asia-Taiwan International Conference and Exhibition will run July 24-28 at Taipei Nangang Exhibition Hall, with 20 advanced biotech countries to set up national pavilions and many multinational pharmaceutical brands, medical materials suppliers and biotech service specialists to showcase their latest offerings at a total of 1,600 booths, according to show organizers.

The event will witness the world's heavyweights in the biotech sector deliver keynote speeches on the latest global biotech development trends, including Harvard University professor Jeffery Karp, rated by MIT's Technology Review Magazine as the world's top biotech innovator, and James C Greenwood, president and CEO of the Biotechnology Innovation Organization (BIO) in Washington DC.

In addition, many international pharmaceutical brands including Merck, IQVIA, MSD, Johnson & Johnson, and Roche and Lilly will also join forces with leading hospitals in Taiwan to showcase their smart healthcare solutions at the event bearing the theme "Healthcare X IT."

Looking for startups?
Profiles of startups from Taiwan and around the world: their technologies, product developments, fundraising rounds, etc. All startups are welcome to register their profiles - free of charge.
Information about accelerators and incubators from Taiwan and around the world that are mentoring startup businesses and teams. All mentors are welcome to register their info - free of charge.
Major events, including those organized by the government, DIGITIMES, and others, featuring startups, innovative technologies and products from Taiwan, Asia and around the world.
Realtime news

Global LCD panel shipment forecast, 2021 and beyond

Taiwan LCD monitors – 3Q 2020

Taiwan LCD TVs – 3Q 2020

Global server shipment forecast and industry analysis, 2021

China semiconductor industry: From 13th 5-year Plan to 14th 5-year Plan, 2015-2025

Global LCD panel shipment forecast, 2021 and beyond

This website adheres to all nine of NewsGuard's standards of credibility and transparency.
© 2021 DIGITIMES Inc. All rights reserved.
Please do not republish, publicly broadcast or publicly transmit content from this website without written permission from DIGITIMES Inc. Please contact us if you have any questions.